Geneva, June 4 -- International Clinical Trials Registry received information related to the study (NCT06743243) titled 'Effect of Tegoprazan for Elective Surgery Patients Under General Anesthesia' on Dec. 16, 2024.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Triple (Participant, Investigator, Outcomes Assessor).
Primary Sponsor: Kim, Young Sung
Condition:
Ordinary Disorder Needed Planned Surgery and General Anesthesia
Intervention:
Drug: Tegoprazan
Drug: Famotidine
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: March 2025
Target Sample Size: 174
Countries of Recruitment:
Korea, Republic of
To ...